A retrospective ‘real-world’ cohort study of azole therapeutic drug monitoring and evolution of antifungal resistance in cystic fibrosis

BACKGROUND: Individuals with cystic fibrosis (CF) have an increased susceptibility to fungal infection/allergy, with triazoles often used as first-line therapy. Therapeutic drug monitoring (TDM) is essential due to significant pharmacokinetic variability and the recent emergence of triazole resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Paolo, M, Hewitt, L, Nwankwo, E, Ni, M, Vidal-Diaz, A, Fisher, M C, Armstrong-James, D, Shah, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210303/
https://www.ncbi.nlm.nih.gov/pubmed/34223100
http://dx.doi.org/10.1093/jacamr/dlab026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210303/
https://www.ncbi.nlm.nih.gov/pubmed/34223100
http://dx.doi.org/10.1093/jacamr/dlab026

Ejemplares similares